Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
106-120 of 2230 results
US FTC approves Teva’s $40.5bn deal for Allergan’s generics business
By PBR Staff Writer
The US Federal Trade Commission (FTC) has approved Teva Pharmaceutical Industries’ proposed $40.5bn acquisition of Allergan’s generics business.
Production & Manufacturing > Manufacturing > News
Just Biotherapeutics secures $14M series A2 funding
Just Biotherapeutics, an organization dedicated to expanding global access to important protein therapeutics, announced the closing of a $14M Series A2 financing round.
Production & Manufacturing > Manufacturing > News
Scancell appoints Eurogentec SCIB1 material manufacturer
Scancell has signed an agreement with Eurogentec for the manufacture of new supplies of Scancell’s SCIB1 ImmunoBody vaccine for use in the US clinical study of SCIB1 in combination with a checkpoint inhibitor, expected to commence in 2017.
Production & Manufacturing > Manufacturing > News
Shire acquires stake in Chronos Therapeutics
By PBR Staff Writer
Shire has acquired a stake in Chronos Therapeutics, a UK-based privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders.
Production & Manufacturing > Manufacturing > News
MilliporeSigma starts work on $115m life science campus in Massachusetts
By PBR Staff Writer
MilliporeSigma has started construction on a $115m multi-faceted life science campus in Burlington, Massachusetts, US.
Production & Manufacturing > Manufacturing > News
AstraZeneca, Sandoz resolve Faslodex patent litigation in US
By PBR Staff Writer
AstraZeneca has signed an agreement with Sandoz, the generic pharmaceuticals division of Novartis, to resolve Faslodex (fulvestrant) patent litigation in the US.
Production & Manufacturing > Manufacturing > News
Funds advised by Apax Partners agree to buy operating subsidiaries of Invent Farm
By PBR Staff Writer
Funds advised by Apax Partners have agreed to acquire the operating subsidiaries of Spanish pharmaceutical firm Invent Farm from a consortium of investors led by Silfurberg, Framtakssjóður Íslands and Horn II.
Production & Manufacturing > Manufacturing > News
Teligent advances $50m facility expansion in Buena
Teligent has broken ground on the ongoing expansion of its manufacturing and research and development complex in Buena, NJ.
Production & Manufacturing > Manufacturing > News
Aprecia Pharmaceuticals signs $30m debt financing agreement with Hercules Capital
Aprecia Pharmaceuticals, a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, has entered into an up to $30m debt financing agreement with Hercules Capital.
Production & Manufacturing > Manufacturing > News
AstraZeneca divests two dermatology drug rights to LEO Pharma
By PBR Staff Writer
AstraZeneca has sold the rights to develop tralokinumab drug to treat atopic dermatitis to LEO Pharma.
Production & Manufacturing > Manufacturing > News
Merck to develop vaccine manufacturing processes with International Vaccine Institute
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
Production & Manufacturing > Manufacturing > News
Intensity Therapeutics raises $10m to fund clinical supplies manufacturing and phase I/II trials of INT230-6
Intensity Therapeutics, a privately held biotechnology company developing proprietary cancer immunotherapy products, has secured $10 million in new capital from a Series A preferred stock financing.
Production & Manufacturing > Manufacturing > News
Sanofi, Boehringer Ingelheim to swap animal, consumer health assets
By PBR Staff Writer
Sanofi and Boehringer Ingelheim have signed contracts to exchange their respective animal health and consumer healthcare businesses.
Production & Manufacturing > Manufacturing > News
Kite Pharma opens T-Cell therapy manufacturing facility in California
Kite Pharma has opened its new commercial manufacturing facility in El Segundo, California.
Production & Manufacturing > Manufacturing > News
FDA accepts Emergent's sLBA for large-scale manufacturing of BioThrax in Building 55
The US Food and Drug Administration (FDA) has accepted for review Emergent BioSolutions' supplemental Biologics License Application (sBLA) seeking approval of the manufacture of BioThrax (Anthrax Vaccine Adsorbed) in Building 55, the company’s large-scale manufacturing facility.
Production & Manufacturing > Manufacturing > News
106-120 of 2230 results